Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Vani Vannappagari"'
Autor:
Vani Vannappagari, Scott McCallister, Beth Romach, Mark Bush, Dinesh Stanislaus, Charlotte Root, Christine Lampkin, Nneka Nwokolo, Ana Puga, Sebastian Moreira, Farzaneh Salem, Ralph DeMasi, Nassrin Payvandi, Kimberly Smith, Harmony Garges, Annemiek de Ruiter
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1391-1398 (2024)
Externí odkaz:
https://doaj.org/article/354bfc4390694dc7bdb524497eb31c46
Autor:
John F P Bridges, Patrick S Sullivan, Vani Vannappagari, Sam Wilson Cole, Jennifer L Glick, Nicola B Campoamor, Travis H Sanchez, Supriya Sarkar, Alex Rinehart, Keith Rawlings
Publikováno v:
BMJ Open, Vol 14, Iss 4 (2024)
Introduction Cabotegravir long-acting injectable HIV pre-exposure prophylaxis (LA-PrEP) was shown to be safe and effective in multiple clinical trials. Increasing uptake and persistence among populations with elevated risk for HIV acquisition, especi
Externí odkaz:
https://doaj.org/article/e39c9d6ac4284b7eb940c0e39fdd7117
Autor:
Kim Anderson, Emma Kalk, Alexa Heekes, Florence Phelanyane, Nisha Jacob, Andrew Boulle, Ushma Mehta, Reshma Kassanjee, Gayathri Sridhar, Leigh Ragone, Vani Vannappagari, Mary‐Ann Davies
Publikováno v:
Journal of the International AIDS Society, Vol 27, Iss 3, Pp n/a-n/a (2024)
Abstract Introduction Monitoring mother‐infant pairs with HIV exposure is needed to assess the effectiveness of vertical transmission (VT) prevention programmes and progress towards VT elimination. Methods We used routinely collected data on infant
Externí odkaz:
https://doaj.org/article/f6e7e5705a5a447e9d9b4122f9d71c2c
Autor:
Michael G. Sension, Laurence Brunet, Ricky K. Hsu, Jennifer S. Fusco, Quateka Cochran, Christine Uranaka, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Lewis McCurdy, Michael B. Wohlfeiler, Gregory P. Fusco
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 12, Pp 2807-2817 (2023)
Abstract Introduction The first complete long-acting antiretroviral therapy (ART) regimen, cabotegravir + rilpivirine long-acting (CAB + RPV LA) injectable, was approved in the US for HIV-1 treatment in individuals on a stable antiretroviral regimen
Externí odkaz:
https://doaj.org/article/4d491b7ec6474e8391338563f1ac2e28
Autor:
Ricky K. Hsu, Jennifer S. Fusco, Cassidy E. Henegar, Vani Vannappagari, Andrew Clark, Laurence Brunet, Philip C. Lackey, Gerald Pierone, Gregory P. Fusco
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Multi-class resistance, intolerance, and drug–drug interactions can result in unique antiretroviral (ART) combinations for heavily treatment-experienced (HTE) people living with HIV (PLWH). We aimed to compare clinical outcomes
Externí odkaz:
https://doaj.org/article/f309de0965ef4a1da836818b3bd1a52a
Autor:
Cassidy Henegar, Emilio Letang, Ruolan Wang, Charles Hicks, Dainielle Fox, Bryn Jones, Annemiek de Ruiter, Vani Vannappagari
Publikováno v:
Viruses, Vol 15, Iss 12, p 2426 (2023)
After a decade of dolutegravir (DTG) use in various antiretroviral therapy combinations and in diverse populations globally, it is critical to identify HIV strains with reduced drug susceptibility and monitor emergent resistance in people living with
Externí odkaz:
https://doaj.org/article/5e4258e6fd074057a87d7196a6010221
Autor:
Cristina Mussini, Fiona Burns, Shema Tariq, Fiona M Burns, Caroline Sabin, Udi Davidovich, Bruno Spire, John Gill, Marc van der Valk, Linda Wittkop, Laurence Meyer, Kholoud Porter, Inés Suárez-García, Giota Touloumi, Lars Eriksson, Sophie Grabar, Santiago Moreno, Emily Jay Nicholls, Christina Carlander, Elisa Ruiz-Burga, Alain Volny Anne, Inma Jarrin, Nikos Pantazis, Rafael Eduardo Campo, Harmony Garges, Barbara Pinto, Vani Vannappagari, Lital Young, Agnes Aisam, Diana Barger, Marie Dos Santos, Eli Fitzgerald, Argyro Karakosta, Hartmut Krentz, Nicoletta Policek, Chris Sandford
Publikováno v:
BMJ Open, Vol 13, Iss 5 (2023)
Introduction Despite the availability of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART), 21 793 people were newly diagnosed with HIV in Europe in 2019. The Concerted action on seroconversion to AIDS and death in Europe study aims to
Externí odkaz:
https://doaj.org/article/70d0ce1819e04eef99f3cbe5329ce34e
Autor:
Annegret Pelchen-Matthews, Jakob Friis Larsen, Leah Shepherd, Josip Begovac, Karen Pedersen, Stéphane De Wit, Andrzej Horban, Elzbieta Jablonowska, Margaret Johnson, Irina Khromova, Marcelo H. Losso, Lars N. Nielsen, Anna Lisa Ridolfo, Brigitte Schmied, Christoph Stephan, Israel Yust, Lloyd Curtis, Vani Vannappagari, Leigh Ragone, Ashley Roen, Dorthe Raben, Ole Kirk, Lars Peters, Amanda Mocroft, for the EuroSIDA Study Group
Publikováno v:
HIV Research & Clinical Practice, Vol 22, Iss 6, Pp 160-168 (2021)
Background: Hypersensitivity reaction (HSR) and hepatotoxicity are rare, but potentially serious side-effects of antiretroviral use. Objective: To investigate discontinuations due to HSR, hepatotoxicity or other reasons among users of dolutegravir (D
Externí odkaz:
https://doaj.org/article/19ba791aac3342e2ac27b1f0aef3c856
Autor:
Karam Mounzer, Ricky Hsu, Jennifer S. Fusco, Laurence Brunet, Cassidy E. Henegar, Vani Vannappagari, Chris M. Stainsby, Mark S. Shaefer, Leigh Ragone, Gregory P. Fusco
Publikováno v:
AIDS Research and Therapy, Vol 16, Iss 1, Pp 1-9 (2019)
Abstract Background HLA-B*57:01 screening was added to clinical care guidelines in 2008 to reduce the risk of hypersensitivity reaction from abacavir. The uptake of HLA-B*57:01 screening and incidence of hypersensitivity reaction were assessed in a p
Externí odkaz:
https://doaj.org/article/eb6a93f967da4fe48e4500da57276d04
Autor:
Michael Wohlfeiler, Karam Mounzer, Laurence Brunet, Jennifer Fusco, Vani Vannappagari, Lloyd Curtis, Nassrin Payvandi, Michael Aboud, Ricky Hsu, Philip Lackey, Gregory Fusco
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 11 (2020)
Introduction: A comprehensive assessment of liver disorders was conducted among people living with HIV (PLWH) on a new antiretroviral regimen based on common core agents. Methods: Treatment-naïve and experienced PLWH first initiating dolutegravir (D
Externí odkaz:
https://doaj.org/article/5c8a953b882f4526933a71880c12ec3c